210 related articles for article (PubMed ID: 25979768)
1. Purinergic signalling in the urinary bladder.
Andersson KE
Auton Neurosci; 2015 Sep; 191():78-81. PubMed ID: 25979768
[TBL] [Abstract][Full Text] [Related]
2. Control of bladder function by peripheral nerves: avenues for novel drug targets.
Fry CH; Ikeda Y; Harvey R; Wu C; Sui GP
Urology; 2004 Mar; 63(3 Suppl 1):24-31. PubMed ID: 15013649
[TBL] [Abstract][Full Text] [Related]
3. Urothelial purine release during filling of murine and primate bladders.
Durnin L; Hayoz S; Corrigan RD; Yanez A; Koh SD; Mutafova-Yambolieva VN
Am J Physiol Renal Physiol; 2016 Oct; 311(4):F708-F716. PubMed ID: 27465992
[TBL] [Abstract][Full Text] [Related]
4. Purinergic signalling underlies transforming growth factor-β-mediated bladder afferent nerve hyperexcitability.
Gonzalez EJ; Heppner TJ; Nelson MT; Vizzard MA
J Physiol; 2016 Jul; 594(13):3575-88. PubMed ID: 27006168
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic perspective on the physiology of the lower urinary tract.
Andersson KE; Hedlund P
Urology; 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1. PubMed ID: 12493344
[TBL] [Abstract][Full Text] [Related]
6. Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis.
Birder LA; Ruan HZ; Chopra B; Xiang Z; Barrick S; Buffington CA; Roppolo JR; Ford AP; de Groat WC; Burnstock G
Am J Physiol Renal Physiol; 2004 Nov; 287(5):F1084-91. PubMed ID: 15251862
[TBL] [Abstract][Full Text] [Related]
7. Purinergic signalling in the urinary tract in health and disease.
Burnstock G
Purinergic Signal; 2014 Mar; 10(1):103-55. PubMed ID: 24265069
[TBL] [Abstract][Full Text] [Related]
8. Pannexin 1 channels mediate the release of ATP into the lumen of the rat urinary bladder.
Beckel JM; Daugherty SL; Tyagi P; Wolf-Johnston AS; Birder LA; Mitchell CH; de Groat WC
J Physiol; 2015 Apr; 593(8):1857-71. PubMed ID: 25630792
[TBL] [Abstract][Full Text] [Related]
9. Urothelial ATP exocytosis: regulation of bladder compliance in the urine storage phase.
Nakagomi H; Yoshiyama M; Mochizuki T; Miyamoto T; Komatsu R; Imura Y; Morizawa Y; Hiasa M; Miyaji T; Kira S; Araki I; Fujishita K; Shibata K; Shigetomi E; Shinozaki Y; Ichikawa R; Uneyama H; Iwatsuki K; Nomura M; de Groat WC; Moriyama Y; Takeda M; Koizumi S
Sci Rep; 2016 Jul; 6():29761. PubMed ID: 27412485
[TBL] [Abstract][Full Text] [Related]
10. ATP released via pannexin-1 hemichannels mediates bladder overactivity triggered by urothelial P2Y6 receptors.
Timóteo MA; Carneiro I; Silva I; Noronha-Matos JB; Ferreirinha F; Silva-Ramos M; Correia-de-Sá P
Biochem Pharmacol; 2014 Jan; 87(2):371-9. PubMed ID: 24269631
[TBL] [Abstract][Full Text] [Related]
11. Purinoceptors as therapeutic targets for lower urinary tract dysfunction.
Ford AP; Gever JR; Nunn PA; Zhong Y; Cefalu JS; Dillon MP; Cockayne DA
Br J Pharmacol; 2006 Feb; 147 Suppl 2(Suppl 2):S132-43. PubMed ID: 16465177
[TBL] [Abstract][Full Text] [Related]
12. Activation of P2Y6 Receptors Facilitates Nonneuronal Adenosine Triphosphate and Acetylcholine Release from Urothelium with the Lamina Propria of Men with Bladder Outlet Obstruction.
Silva I; Ferreirinha F; Magalhães-Cardoso MT; Silva-Ramos M; Correia-de-Sá P
J Urol; 2015 Oct; 194(4):1146-54. PubMed ID: 26004864
[TBL] [Abstract][Full Text] [Related]
13. Purinergic P2X3 heteroreceptors enhance parasympathetic motor drive in isolated porcine detrusor, a reliable model for development of P2X selective blockers for detrusor hyperactivity.
D'Agostino G; Condino AM; Calvi V; Boschi F; Gioglio L; Barbieri A
Pharmacol Res; 2012 Jan; 65(1):129-36. PubMed ID: 22041665
[TBL] [Abstract][Full Text] [Related]
14. ATP enhances spontaneous calcium activity in cultured suburothelial myofibroblasts of the human bladder.
Cheng S; Scigalla FP; Speroni di Fenizio P; Zhang ZG; Stolzenburg JU; Neuhaus J
PLoS One; 2011; 6(10):e25769. PubMed ID: 21998694
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of urothelial P2X3 receptors prevents desensitization of purinergic detrusor contractions in the rat bladder.
Ferguson AC; Sutton BW; Boone TB; Ford AP; Munoz A
BJU Int; 2015 Aug; 116(2):293-301. PubMed ID: 25430615
[TBL] [Abstract][Full Text] [Related]
16. Expression and localization of pannexin-1 and CALHM1 in porcine bladder and their involvement in modulating ATP release.
Sana-Ur-Rehman H; Markus I; Moore KH; Mansfield KJ; Liu L
Am J Physiol Regul Integr Comp Physiol; 2017 May; 312(5):R763-R772. PubMed ID: 28254749
[TBL] [Abstract][Full Text] [Related]
17. Purinergic signalling in the lower urinary tract.
Burnstock G
Acta Physiol (Oxf); 2013 Jan; 207(1):40-52. PubMed ID: 23176070
[TBL] [Abstract][Full Text] [Related]
18. Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A.
Smith CP; Vemulakonda VM; Kiss S; Boone TB; Somogyi GT
Neurochem Int; 2005 Sep; 47(4):291-7. PubMed ID: 15970360
[TBL] [Abstract][Full Text] [Related]
19. Expression of P2X3 purinoceptors in suburothelial myofibroblasts of the normal human urinary bladder.
Liu F; Takahashi N; Yamaguchi O
Int J Urol; 2009 Jun; 16(6):570-5. PubMed ID: 19456993
[TBL] [Abstract][Full Text] [Related]
20. Bladder activation: afferent mechanisms.
Andersson KE
Urology; 2002 May; 59(5 Suppl 1):43-50. PubMed ID: 12007522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
